Search research articles
Contact Us
Filters
Showing results (391-400 of 402) with videos related to
Page
of 41
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 23, 2026
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
The Journal of Urology
|
January 10, 2004
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement
Ian M Thompson, Demetrius Albanes, Joseph W Basler, et al.
Oncogene
|
April 8, 2014
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity
N Li, K Lee, Y Xi, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer
|
March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 29, 2021
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
Kevin J Lee, Wen-Chi L Chang, Xi Chen, et al.
Clinical Transplants
|
July 22, 2008
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis
M Ozawa, P I Terasaki, R Castro, et al.
Pharmacological Reviews
|
March 13, 2025
Cyclic nucleotide phosphodiesterases as drug targets
Michy P Kelly, Viacheslav O Nikolaev, Leila Gobejishvili, et al.
Cancer Research
|
December 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer
Jeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Tissue Antigens
|
April 21, 2007
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project
M Ozawa, P I Terasaki, J H Lee, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 402) with videos related to
Sort By:
Page
of 41
Biorxiv : the Preprint Server for Biology
|
February 23, 2026
ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
The Journal of Urology
|
January 10, 2004
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement
Ian M Thompson, Demetrius Albanes, Joseph W Basler, et al.
Oncogene
|
April 8, 2014
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity
N Li, K Lee, Y Xi, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer
|
March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 29, 2021
Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin
Kevin J Lee, Wen-Chi L Chang, Xi Chen, et al.
Clinical Transplants
|
July 22, 2008
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis
M Ozawa, P I Terasaki, R Castro, et al.
Pharmacological Reviews
|
March 13, 2025
Cyclic nucleotide phosphodiesterases as drug targets
Michy P Kelly, Viacheslav O Nikolaev, Leila Gobejishvili, et al.
Cancer Research
|
December 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer
Jeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Tissue Antigens
|
April 21, 2007
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project
M Ozawa, P I Terasaki, J H Lee, et al.
Page
of 41